pyridoxamine and transforming growth factor beta

pyridoxamine has been researched along with transforming growth factor beta in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolton, WK; Turgut, F1
Deng, Z; Lin, F; Lin, H; Sun, C; Yu, H; Zhou, C; Zhu, P; Zhuo, X1
Cai, W; Choi, R; Elliot, SJ; Pereira-Simon, S; Rubio, GA; Striker, GE; Xia, X1

Reviews

1 review(s) available for pyridoxamine and transforming growth factor beta

ArticleYear
Potential new therapeutic agents for diabetic kidney disease.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 55, Issue:5

    Topics: Amides; Animals; Clinical Trials as Topic; Connective Tissue Growth Factor; Diabetic Nephropathies; Disease Progression; Endothelin Receptor Antagonists; Glycation End Products, Advanced; Glycosaminoglycans; Guanidines; Humans; Hydrazines; Kidney; NADPH Oxidases; Nitric Oxide Synthase; Pentoxifylline; Phosphodiesterase Inhibitors; Pyridines; Pyridoxamine; Pyrimidines; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vitamin B Complex

2010

Other Studies

2 other study(ies) available for pyridoxamine and transforming growth factor beta

ArticleYear
Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats.
    Molecular medicine reports, 2012, Volume: 5, Issue:3

    Topics: Animals; Benzimidazoles; Benzoates; Drug Synergism; Glycation End Products, Advanced; Kidney; Male; Malondialdehyde; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Protective Agents; Pyridoxamine; Rats; Rats, Inbred SHR; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Superoxide Dismutase; Telmisartan; Transcription Factor RelA; Transforming Growth Factor beta

2012
Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
    PloS one, 2016, Volume: 11, Issue:7

    Topics: Aging; Animals; Antioxidants; Collagen Type IV; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation; Glycation End Products, Advanced; Hormone Replacement Therapy; Kidney Glomerulus; Mesangial Cells; Mice; Mice, Inbred C57BL; Ovariectomy; Oxidative Stress; Primary Cell Culture; Pyridoxamine; Receptor for Advanced Glycation End Products; RNA, Messenger; Serum Albumin, Bovine; Signal Transduction; Sirtuin 1; Transforming Growth Factor beta

2016